Why the study?
Does resveratrol reduce ischemia- and ischemia-reperfusion-induced arrhythmias and mortality in a rat model?
Population
Anesthetized rats subjected to left main coronary artery occlusion for 30 or 5 min followed by a 30-min…
Comparison
Preinfusion with resveratrol before occlusion vs No resveratrol preinfusion
Design
Preclinical
Follow-up
30-min reperfusion
Authors
Loading...
Resveratrol attenuates reperfusion arrhythmias in rats; hypothesis-generating and leaves open any clinical translation.
Does resveratrol reduce ischemia- and ischemia-reperfusion-induced arrhythmias and mortality in a rat model?
Resveratrol demonstrates potent antiarrhythmic and cardioprotective properties against ischemia-reperfusion injury in a rat model, potentially mediated by antioxidant activity and NO upregulation.
Linda Hung (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: